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Abstract: The in situ formation of silver nanoparticles (AgNPs) aided by chondroitin sulfate and the
preparation of a hierarchically structured silver-polymer nanocomposite with antimicrobial activity is
shown. Green synthesis of AgNPs is carried out by thermal treatment (80 and 90 ˝C) or UV irradiation
of a chondroitin sulfate solution containing AgNO3 without using any further reducing agents or
stabilizers. Best control of the AgNPs size and polydispersity was achieved by UV irradiation.
The ice-segregation-induced self-assembly (ISISA) process, in which the polymer solution containing
the AgNPs is frozen unidirectionally, and successively freeze-drying were employed to produce
the chondroitin sulfate 3D scaffolds. The scaffolds were further crosslinked with hexamethylene
diisocyanate vapors to avoid water solubility of the 3D structures in aqueous environments.
The antimicrobial activity of the scaffolds was tested against Escherichia coli. The minimum inhibitory
concentration (MIC) found for AgNPs-CS (chondroitin sulfate) scaffolds was ca. 6 ppm.
Keywords: chondroitin sulfate; nanoparticles; silver; scaffolds
1. Introduction
The synergy among entities of a different nature that is found in nanocomposites will perform a
key function in the progress of advanced functional materials in diverse fields, mainly in biomedical
applications [1]. Keeping in mind the strict biocompatibility requirements of biomedical devices, the
use of green methods for nanoparticle preparation is crucial [2]. Otherwise, detrimental effects on
biological entities can easily occur due to the use, during and/or post synthesis, of non-biocompatible
chemical reagents such as reducing agents, residual solvents or surfactants among others which, in
the end, may be difficult to remove from the reaction media by practical manufacturing techniques.
Furthermore, the assembly of nanoparticles into macroscopic materials is attracting much attention [3].
Thus, progress in this field depends largely on the core competence of materials scientists to create new
synthetic approaches (mainly derived from bottom-up techniques) for the development of advanced
materials with nano- and microstructures and unmatched achievements [4–6]. Thus, we should not
only be able to produce nanostructures, controlling both their shape and size, but also to build them in
any appearance and to produce hierarchically organized structures so that accessibility to the inner
interfaces is guaranteed [7].
Any green synthetic approach needs to consider the use of harmless chemicals and solvents,
environmentally safe reducing agents and renewable materials. Moreover, the in situ preparation
of the nanocomposites into the demanded structure (e.g., nanoparticles, particles, fibers, capsules,
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scaffolds, etc.) can also be of help to further enhance the overall biocompatibility of the preparation
process by reduction of manipulation steps that may finally lead to contamination [8].
Silver nanoparticles (AgNPs) have optical, antimicrobial and electrical properties that depend
both on their size and shape. Ag+ reduction to Ag nanoparticles can be carried out by chemical methods
using reducing agents such as glucose, sodium borohydrate, ascorbic acid, etc., by electrochemical
methods via photochemical processes, or by radiation [9]. In a first step, silver atoms (Ag0) are reduced
to silver ions (Ag+), which is followed by agglomeration into oligomeric clusters, and finally ends in
the formation of colloidal Ag particles. Due to the tendency of the AgNPs to aggregate, it is necessary
to use capping agents to stabilize the AgNPs.
Several examples of AgNPs synthesis in the presence of naturally occurring stabilizers such
as cellulose, chitosan, heparin and starch, among others, have been reported [10–12]. The use of
chondroitin sulfate (CS) to produce AgNPs has also been reported, with the polymer acting both as
a reducing and stabilizing agent by capping the AgNPs [13]. CS is a sulfated glycosaminoglycan
(Figure 1) that has attracted great interest as a biocompatible and biodegradable polymer employed
in pharmaceutical and biomedical devices. CS has been applied in cartilage regeneration, bone
regeneration, skin regeneration or neuronal regeneration [14]. Recently, 3D nanocomposites composed
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Figure 1. Che ical structure of chondroitin-4-sulfate, where R1 = ; 2 3 ; 3 = H.
The management of infections associated with surgical implants can be both complicated
and costly. Therefore, the prevention of such infections by developing medical devices containing
antimicrobial agents is a topic of great interest.
AgNPs thermally pr duced in the presence f chondroitin sulfate and their use in an intment
with antibacterial properties nd in vivo woun healing a tivity has been recently reported [16], but to
our knowledge, the green synthesis of AgNPs-CS three-dimensional nanocomposites with antibacterial
activity has not been reported.
2. Results and Discussion
2.1. AgNPs Production and Characterization
In this paper, we report the green synthesis of 3D structured hierarchically nanocomposites, in
particular of silver nanoparticles entrapped within chondroitin sulfate scaffolds (AgNPs-CS scaffolds).
AgNPs were obtained by reduction of silver salts in an aqueous solution of chondroitin sulfate by
thermal treatments (80 and 90 ˝C) or by UV light irradiation [17]. During the different treatments, a
yellow color appeared in the solutions over time, indicating the formation of AgNPs. The intensity of
the silver exciton peak at 400 nm [18] was used as an indicator of nanoparticle synthesis and growth,
as seen in Figure 2.





























Figure 2. UV-Vis spectra of silver-containing chondroitin sulphate solutions (CS 10 wt% and 0.16 mM
AgNO3) after thermal treatment at 80 ˝C (A) and 90 ˝C (B) and UV-treatment (C). Thermal treatments
were performed over 0, 90, 120, 210 and 270 min (lines a, b, c, d and e, respectively). UV treatments
were performed over 120, 180 and 240 min (lines a, b and c). Sample irradiated during 240 min rested
24 h before measuring the exciton peak (line d).
The band broadening and red shift shown in the spectra of the AgNPs produced by the thermal
treatment (90 ˝C) point to large AgNPs and wide size distribution, and therefore this method was
rejected for producing the AgNPs. As seen in Figure 2A,C, AgNPs produced by thermal treatment
(80 ˝C) and UV irradiation showed narrower spectra centered at 445 nm. Interestingly, the intensity
of the AgNPs exciton increased after resting the UV-irradiated solution 24 h in the dark before
the measurement.
As controls, AgNO3 solutions without polymer were also thermally treated or irradiated and the
absorbance of the solution was monitored over time. In both cases, no AgNPs formation was detected
under the experimental conditions.
AgNPs were spherical in shape and the samples produced by the thermal treatment were larger
than those produced by UV irradiation (Figure 3). The 24 h resting period seems to be necessary for
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i r 3. rans issi electro icrosc ( ) icr r f s- r t r l
t t ˝ ( ); V i radiation of fresh sample (B); and sample rested for 24 h (C). Bars are
50 nm in panel (A) and 20 nm i panels (B) and (C). CS: cho droitin sulfate.
Trans ission electron icroscopy (TE ) icrographs were used to deter ine the AgNPs’ size
distribution; at least 100 AgNPs were analyzed using Image J software. As seen in Figure 4, more than
90% of the AgNPs produced by UV irradiation had a particle size lower than 10 nm while the AgNPs
produced by thermal treatment (80 ˝C) had a bimodal distribution with particle sizes centered in the
range of 1–10 nm and 20–40 nm, respectively.
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is  highly  soluble  in  water,  the  scaffold  was  subsequently  crosslinked  with  hexamethylene 
diisocyanate vapors at 60 °C over one week to avoid its dissolution in aqueous media. 
As  confirmed  by  Scanning  electron  microscopy  (SEM),  the  resulting  crosslinked  scaffold 
exhibited a uniform and porous 3D structure along the whole scaffold, with a pore size range between 
Figure 4. Particle size distribution estimated from TE micrographs of AgNPs produced by UV
treat ent (A) and by ther al treat ent (B). N =100.
The metallic nature of the AgNPs was corroborated by selected-area electron diffraction (SAED)
and X-ray photoelectron spectroscopy (XPS) (Figure 5). The corresponding SAED pattern showed the
main diffraction rings that can be assigned as (111), (200), (220) and (311) reflections, which corresponds
to the face-centered cubic structure of metallic silver. Moreover, the XPS analysis revealed the presence
of Ag 3d5/2 and Ag 3d3/2 doublet peaks typical of metallic silver at binding energies of 367.8 and
373.8 eV, respectively, with a spin-orbit separation of 6.0 eV. The yield of the reduction process was
around 100% since no Ag+ was detected.
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Figure 5. Metallic natur of AgNPs. Diffraction pattern (A) and X-ray photoelectron spectroscopy
(XPS) spectrum (B) of the AgNPs produced by UV irradiation.
2.2. AgNPs-CS Scaffold Preparation and Characterization
I has been w ll recognized since ancient mes that met llic silver displays antimicrobial
activit es, but its u e was relegated by modern antibiotics in the last decad s [19]. The emergence
of bacterial resistances to frequently u ed antibiotics has be n a key factor in the considerabl
ttent on th t AgNP have gain d in the last years. In general, the smaller the particle size is, th
g ter the antimicrobial effect is. This can be explained by the fact tha small size implies large
avail ble surfac areas, hig r silver ion release and imp oved interacti ns wit other particles [20,21].
aking this into account, we selected the AgNPs produced by UV rra iation to produce the
AgNPs-CS scaffolds. The resulting irradiat d polymer solution containing AgNPs was submitted
to t e ice-segregatio -induced self-assembly (ISISA) process for the formation of a m croporous
monolith [22]. Because CS is highly soluble in water, the scaffold was subs q ently crosslinked with
hexamethylene diisoc anate vapors at 60 ˝C ove one week to avoid its dissolution in aqu ou media.
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As confirmed by Scanning electron microscopy (SEM), the resulting crosslinked scaffold exhibited
a uniform and porous 3D structure along the whole scaffold, with a pore size range between 10 and


























as  0 ppm  in Figure  8), E.  coli grew  in  the  culture media. That means  that CS did not  exert  any 
Figure 6. Scanning electron microscopy (SEM) micrograph of AgNPs-CS crosslinked scaffold.
Bar 50 µm.
2.3. Silver Rele se from AgNPs-CS Crosslinked Scaffolds
Since the antimicrobial properties of the scaffold will depend on its ability to release silver to
the media, the silver release from the AgNPs-CS crosslinked scaffolds was studied in physiological
conditions (phosphate saline buffer (PSB) at 37 ˝C). As seen in Figure 7, the release of the silver from
the scaffolds was very fast, with around 60% of the silver released from the scaffolds in the first hour.
Moreover, after 6 h more than 95% of the silver was released from the scaffold. This release pattern
is in good agreement with the silver release from a hydrophilic matrix, in which the hydrophilic
polymeric matrix highly swells in aqueous media, allowing a fast release of the antimicrobials from
the matrix [23]. Therefore, the minimum inhibitory concentration is largely exceeded in a short time,
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as  0 ppm  in Figure  8), E.  coli grew  in  the  culture media. That means  that CS did not  exert  any 
Figure 7 Silver release from AgNPs-CS crosslinked scaffolds in phosphate saline buffer (PSB) at 37 ˝C.
N =2.
2.4. g Ps- S nti icrobial ctivity
The anti icrobial activity of the AgNPs entrapped in th CS caffol s was studied. To ascert i the
mini um inhibit ry concentration of the AgNPs, we dissolved a known amount of a n -crosslinked
scaffold in aqueous media nd differe t aliquots were produced by dilution in PBS. The anti icrobial
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activity of each dilution against E. coli was tested. As seen in Figure 8, the minimum inhibitory
concentration (MIC) found for the AgNPs was ca. 6.2 ppm, in good agreement with data previously
reported [24,25]. When a bare scaffold (sample without silver) was tested (sample denoted as 0 ppm
in Figure 8), E. coli grew in the culture media. That means that CS did not exert any antimicrobial
activity and the observed antimicrobial activity of the AgNPS-CS scaffolds is only ascribed to the
AgNPs incorporated in the scaffold.
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The antibacterial activity of AgNp-CS crosslinked scaffolds, AgNO3-CS crosslinked scaffolds and
CS crosslinked scaffolds was tested against E. coli at 24 h (Figure 9A–C). In all cases, the same amount
of scaffolds (ca. 60 mg) was used; this amount was selected taking into account the silver content of the
scaffolds and guarantees a silver concentration in the culture media larger than the MIC concentration
(around 8 ppm).
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The antimicrobial activity was merely detected in the media contai ing Ps- li
ff l s, while no a timicrobial activity was found when the same amount of AgNO3- cr li
ff l or CS crosslinked scaffold were tested. The lack of antimicrobial activity of the CS crosslinked
sc ffold demonstrated that the antimicrobial activity observed in the AgNPs-CS sslinked scaffold
was not due to hexymethylene diisocy nate toxicity. Interestingly, no antimicrobial activity w s
detected when AgNO3-CS crosslinked scaffolds were tested. To further investigate the antimicrobial
ctivity of AgNO3, two aqueous solutions of AgNO3 (6.25 and 12.5 ppm) were tested. No antimicrobial
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activity was observed at 6.25 ppm while no bacterial growth was observed at 12.5 ppm (Figure 9D,E).
This indicated that AgNPs produced by UV irradiation of a chondroitin sulfate solution have better
antimicrobial activity than AgNO3. The precise antimicrobial mechanism of silver is still not known,
but different mechanisms of action have been suggested, depending on the ionized state of silver,
which may explain the different behavior observed between AgNPs and silver nitrate [26].
3. Materials and Methods
3.1. Materials
AgNO3 with a purity >99.5.0% was purchased from Fluka. Chondroitin 4-sulfate sodium salt (CS)
from bovine trachea was purchased from Sigma. Ultrapure water obtained with a Milli-Q equipment
(Millipore, Billerica, MA, USA) was used as solvent.
3.2. Methods
3.2.1. Preparation of Ag Nanoparticles in Chondroitin Sulfate Solution by Thermal Treatment
First 400 µL of AgNO3 (1 mM) dissolved in water were added to a chondroitin sulfate solution
(10% w/v) and then the mixture was thermally treated at 80 or 90 ˝C at different times in a closed
container to avoid water evaporation.
3.2.2. Preparation of Ag Nanoparticles in chondroitin Sulfate Solution by UV-Irradiation
First 400 µL of AgNO3 (1 M) dissolved in water were added to chondroitin sulfate (10% w/v)
and then the mixture was irradiated (λ = 254 nm) at different times in a home-made dark chamber.
The distance between the lamp and the sample was fixed at 23 cm.
3.2.3. Preparation of AgNPs-Chondroitin Sulfate and AgNO3-Chondroitin Sulfate Scaffolds
To produce AgNPs-CS and AgNO3-CS scaffolds, insulin syringes were filled with the polymer
solutions (irradiated or non-irradiated) containing the AgNPs or AgNO3. The syringes were
unidirectionally frozen by immersion into a liquid nitrogen bath (77 K) at constant rate (2.7 mm/min).
The frozen samples were freeze-dried using a Thermo Savant Micromodulyo freeze-drier. The resulting
samples were monoliths with the geometry of the insulin syringes. Monoliths were further crosslinked
using hexamethylene diisocyanate (HDI) vapors. Briefly, the scaffolds were exposed to HDI vapors
in a closed container at 60 ˝C during one week. After that, the samples were aerated during 48 h.
Non-crosslinked monoliths were also produced.
3.2.4. Sample Characterization
Monoliths morphologies were evaluated by scanning electron microscopy (Zeiss DSM-950
instrument (Zeiss, Oberkochen, Germany). The morphologies and size distribution of AgNPs
were studied by electron transmission microscopy (200 KeV JEOL 2000 FXII; JEOL, Tokyo, Japan).
The selected area electron diffraction (SAED) was used to study the crystallinity. UV/Vis spectrometry
analyses were performed in a Variant Cary 4000 spectrophotometer (Agilent, Santa Clara, CA, USA)
in the wavelength range of 350–600 nm by step of 1 nm. X-ray photoelectron spectroscopy surface
(XPS) analysis was carried out to determine the ionized state of silver. Samples were analyzed using
a VG ESCALAB 200R electron spectrometer (Thermo Fisher Scientific Inc, Waltham, MA, USA).
The equipment is outfitted with a hemispherical electron analyzer (Pass energy: 50 eV) and an Al Kα
120 W X-ray source. The binding energies were referenced to the binding energy of C1s core-level
spectrum at 284.9 eV. Data were acquired and processed using Avantage software provided by the
manufacturer. Shirley background was subtracted previously to spectra decomposition with the
least-squares fitting routine. To determine atomic fraction, peak areas normalized on the basis of
sensitivity factors provided by the manufacturer were used.
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3.2.5. Silver Release
The release of the AgNPs from the AgNPs-CS crosslinked scaffolds in PBS was evaluated.
A known amount of the monolith (ca. 12 mg) was put in 1 mL of PBS at 37 ˝C. The solvent was
completely removed at different times (1, 2, 3, 4, 6 and 24 h) and fresh PBS was added. The removed
PBS solution was dissolved in HNO3 0.1 M and filtered through a 0.45 mm regenerated cellulose filter
(Albet, Relliehausen, Germany). The silver content was determined by inductively coupled plasma
mass spectrometry using a OPTIMA 2100 DV spectrometer (PERKIN ELMER, Waltham, MA, USA).
3.2.6. Antibacterial Activity
To determine the minimum inhibitory concentration (MIC) of the AgNPs included in CS scaffolds,
we used a known amount of non-crosslinked scaffolds with a known silver content. The AgNPs-CS
scaffold was dissolved in 1 mL PBS to completely release the AgNPs included in the scaffold and
dilutions were carried out in PBS. As control a non- crosslinked CS scaffold was also dissolved in
PBS (sample denoted as 0 ppm). Each solution was added to bacteria culture medium (with a final
AgNPs concentration between 0 to 6.25 ppm) and the absorbance at 600 nm was measured during
6 h after bacterial inoculation. To evaluate the antibacterial properties of the scaffolds, E. coli TG1
was grown at 37 ˝C during 24 h in aerated flasks containing Lysogeny broth (LB) medium in the
presence of AgNPs-CS crosslinked scaffolds, AgNO3-CS crosslinked scaffolds and CS cros-slinked
scaffolds (control without silver). AgNO3 aqueous solutions at 6.25 and 12.5 ppm were also tested.
For comparative purposes, the same amount of scaffold (ca. 60 mg) containing around 285 µg of silver
per gram of polymer was used in each experiment.
Acknowledgments: This work was supported by MICINN and CSIC (projects MAT2006-02394 and
200660F011). J. L. Fierro and F. Pinto are acknowledged for helpful support with XPS measurements and
SEM experiments, respectively.
Author Contributions: I. Aranaz conceived and designed the experiments; M. J. Hortiguela, L. Yuste and I. Aranaz
performed the experiments; I. Aranaz, L. Yuste and F. Rojo analyzed the data; I. Aranaz wrote the paper.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
The following abbreviations are used in this manuscript:
AgNPs Silver nanoparticles
CS Chondroitin sulphate
TEM Transmission electron microscopy
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SAED selected-area electron diffraction
ISISA ice-segregation-induced self-assembly
SEMPBS Scanning electron microscopyPhosphate saline buffer
MIC Minimum inhibitory concentration
LB Lysogeny broth medium
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